Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Dronabinol inhalation - Tetra Bio Pharma

Next Previous
Drug Profile

Dronabinol inhalation - Tetra Bio Pharma

Alternative Names: Delta-9-tetrahydrocannabinol - Tetra Bio-Pharma; HCC 011

Latest Information Update: 28 Jan 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Tetra Bio Pharma
  • Class Antidementias; Antiemetics; Antineoplastics; Appetite stimulants; Cannabinoids; Chromans; Muscle relaxants; Non-opioid analgesics; Small molecules
  • Mechanism of Action Cannabinoid receptor CB1 agonists; Cannabinoid receptor CB2 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Liver cancer
  • New Molecular Entity No
  • Available For Licensing Yes - Liver cancer

Highest Development Phases

  • No development reported Liver cancer

Most Recent Events

  • 28 Jan 2023 No recent reports of development identified for phase-I development in Liver-cancer(Adjunctive treatment, First-line therapy) in Canada (Inhalation)
  • 16 Apr 2020 Chemical structure information
  • 06 Apr 2020 Tetra Bio Pharma plans a phase II trial for dronabinol in Liver Cancer (Adjunctive treatment, First-line therapy)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top